全球灌注系統市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計灌注系統市場將從 2025 年的 62.3 億美元成長到 2034 年的 169.3 億美元，2026 年至 2034 年的複合年成長率為 11.76%。

由於器官移植需求不斷成長以及心臟外科手術技術的進步，全球體外循環灌注系統市場正快速成長。體外循環灌注系統在維持手術期間的血液循環和器官存活方面發揮著至關重要的作用。心血管疾病盛行率的上升是推動市場擴張的主要因素。

自動化灌注系統和更先進的監測功能等技術進步是推動市場成長要素。醫院和手術中心正擴大採用這些系統，以提高手術精準度和改善患者預後。此外，醫療基礎設施和研發投入的增加也促進了市場發展。

未來，器官保存技術和攜帶式灌注裝置的創新預計將對市場產生積極影響。微創手術日益受到重視以及外科技術的進步將進一步推動市場需求。隨著全球器官移植率的上升，灌注系統在現代醫學中仍將發揮至關重要的作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球灌流系統市場：依產品類型分類

• 市場分析、洞察與預測
• 心肺灌注系統
• 氧合系統
• 其他

第5章 全球灌流系統市場：依年齡層別分類

• 市場分析、洞察與預測
• 成人
• 兒童

第6章 全球灌流系統市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院及門診手術中心
• 專科診所
• 其他

第7章 全球灌流系統市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • LivaNova Plc
  • XVIVO Perfusion AB
  • TransMedics Inc
  • Getinge AB
  • Medtronic Plc
  • Terumo Corporation
  • Merck KGaA
  • Harvard Bioscience Inc
  • Lifeline Scientific Inc
  • ALA Scientific Instruments Inc

The Perfusion System Market size is expected to reach USD 16.93 Billion in 2034 from USD 6.23 Billion (2025) growing at a CAGR of 11.76% during 2026-2034.

The global perfusion system market is growing rapidly due to increasing demand for organ transplantation and advancements in cardiac surgeries. Perfusion systems play a critical role in maintaining blood circulation and organ viability during surgical procedures. The rising prevalence of cardiovascular diseases is a major factor driving market expansion.

Technological advancements such as automated perfusion systems and improved monitoring capabilities are key growth drivers. Hospitals and surgical centers are increasingly adopting these systems to enhance surgical precision and patient outcomes. Additionally, growing investments in healthcare infrastructure and research are supporting market development.

In the future, the market is expected to benefit from innovations in organ preservation technologies and portable perfusion devices. Increasing focus on minimally invasive procedures and improved surgical techniques will further boost demand. As organ transplantation rates rise globally, perfusion systems will remain essential in modern healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Cardiopulmonary Perfusion Systems
• Oxygenation Systems
• Others

By Age Group

• Adults
• Pediatrics

By End User

• Hospitals & ASCS
• Specialty Clinics
• Others

COMPANIES PROFILED

• LivaNova plc, XVIVO Perfusion AB, TransMedics Inc, Getinge AB, Medtronic plc, Terumo Corporation, Merck KGaA, Harvard Bioscience Inc, Lifeline Scientific Inc, ALA Scientific Instruments Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERFUSION SYSTEM MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Cardiopulmonary Perfusion Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Oxygenation Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERFUSION SYSTEM MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Group
• 5.2. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERFUSION SYSTEM MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals & ASCS Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERFUSION SYSTEM MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Age Group
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Age Group
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Age Group
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Age Group
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Age Group
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PERFUSION SYSTEM INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 LivaNova Plc
  • 9.2.2 XVIVO Perfusion AB
  • 9.2.3 TransMedics Inc
  • 9.2.4 Getinge AB
  • 9.2.5 Medtronic Plc
  • 9.2.6 Terumo Corporation
  • 9.2.7 Merck KGaA
  • 9.2.8 Harvard Bioscience Inc
  • 9.2.9 Lifeline Scientific Inc
  • 9.2.10 ALA Scientific Instruments Inc